Literature DB >> 14756891

Hidradenitis suppurativa: a review.

Marni C Wiseman1.   

Abstract

Hidradenitis suppurativa is a recurrent disease involving apocrine-bearing skin with a predilection for intertriginous areas, including genital skin. It has a highly variable clinical course. Mild cases may present as recurrent isolated nodules, while severe instances of the disease with chronic inflammation may lead to scarring, functional impairment, and rarely, squamous cell carcinoma. While genetic factors, patient characteristics, hormones and infection play a role in disease expression, a comprehensive understanding of the pathogenesis remains to be elicited. Additionally, effective treatment is largely unknown. While the mainstay of therapy had been surgery, and topical or systemic antimicrobial agents, other therapeutic modalities such as retinoids, hormonal therapy and immunosuppresive medications may also hold some promise.

Entities:  

Mesh:

Year:  2004        PMID: 14756891     DOI: 10.1111/j.1396-0296.2004.04007.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  12 in total

Review 1.  Evaluation of perianal fistulas in patients with Crohn's disease.

Authors:  Jennifer Jones; William Tremaine
Journal:  MedGenMed       Date:  2005-05-18

2.  Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa.

Authors:  Ahmed Nader; Denise Beck; Peter Noertersheuser; David Williams; Nael Mostafa
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 6.447

Review 3.  Surgical treatment of hidradenitis suppurativa: case series and review of the literature.

Authors:  Shahzad Ather; David S Y Chan; David J Leaper; Keith G Harding
Journal:  Int Wound J       Date:  2006-09       Impact factor: 3.315

Review 4.  What is hidradenitis suppurativa?

Authors:  Erika Yue Lee; Raed Alhusayen; Perla Lansang; Neil Shear; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

Review 5.  Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.

Authors:  S L Johnston
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

Review 6. 

Authors:  Erika Yue Lee; Raed Alhusayen; Perla Lansang; Neil Shear; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

7.  [Psychiatric comorbidities in hidradenitis suppurativa/acne inversa].

Authors:  Paraskevi Mavrogiorgou; Georg Juckel; Andreas Reimelt; Schapoor Hessam; Lisa Scholl; Jessica Lisa Frajkur; Eggert Stockfleth; Falk G Bechara
Journal:  Hautarzt       Date:  2021-01-04       Impact factor: 0.751

8.  Metastatic Squamous Cell Carcinoma of the Pleura: A Rare Complication of Hidradenitis Suppurativa.

Authors:  Kiran Joglekar; Christopher Jackson; Dipen Kadaria; Amik Sodhi
Journal:  Am J Case Rep       Date:  2016-12-28

9.  Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials.

Authors:  H H van der Zee; M Longcore; Z Geng; A Garg
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-11-19       Impact factor: 6.166

10.  Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.

Authors:  G B E Jemec; M M Okun; S B Forman; W P F Gulliver; E P Prens; U Mrowietz; A W Armstrong; Z Geng; Y Gu; D A Williams; H D Teixeira; A B Kimball
Journal:  Br J Dermatol       Date:  2019-08-14       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.